Synthesis of 2-acetamido-1,2-dideoxy-d-galacto-nojirimycin [DGJNAc] from d-glucuronolactone: the first sub-micromolar inhibitor of α-N-acetylgalactosaminidases

Daniel Best, Phoom Chairatana, Andreas F.G. Glawar, Elizabeth Crabtree, Terry D. Butters, Francis X. Wilson, Chu Yi Yu, Wu Bao Wang, Yue Mei Jia, Isao Adachi, Atsushi Kato, George W.J. Fleet*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

2-Acetamido-1,2-dideoxy-d-galacto-nojirimycin [DGJNAc], prepared in 20% overall yield from d-glucuronolactone, is the first potent competitive sub-micromolar inhibitor of α-N-acetyl-galactosaminidases (Ki 0.081 μM from chicken liver, Ki 0.136 μM from Charonia lampas). DGJNAc is a good competitive-whereas the enantiomer l-DGJNAc is a very weak but non-competitive-inhibitor of β-hexosaminidases.

Original languageEnglish
Pages (from-to)2222-2224
Number of pages3
JournalTetrahedron Letters
Volume51
Issue number17
DOIs
StatePublished - 2010/04/28

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Synthesis of 2-acetamido-1,2-dideoxy-d-galacto-nojirimycin [DGJNAc] from d-glucuronolactone: the first sub-micromolar inhibitor of α-N-acetylgalactosaminidases'. Together they form a unique fingerprint.

Cite this